Clinical trial Recruiting at 2 sites Phase 3 Interventional Ages 18 to 75

HRS-9190 vs Rocuronium for Muscle Relaxation During Anesthesia

Official title: A Phase III, Multicenter, Randomized, Double-Blind, Active-Controlled Study to Evaluate the Efficacy and Safety of Bolus-Administered HRS-9190 Versus Rocuronium for Tracheal Intubation and Maintaining Neuromuscular Blockade During General Anesthesia in Adults Undergoing Elective Surgery

Run by Jiangsu HengRui Medicine Co., Ltd. · NCT07746726 · Data updated 2026-11-12

This Phase 3 trial tests whether HRS-9190 can provide effective muscle relaxation for intubation and surgery as compared with rocuronium in adults undergoing elective general anesthesia.

Quick facts

PhasePhase 3
Study typeInterventional
Ages18 Years to 75 Years
SexAll
Enrollment320 (estimated)
SponsorJiangsu HengRui Medicine Co., Ltd.
Industry-sponsored
Locations2 sites (Changsha, Hunan and 1 other locations)
StatusRecruiting
StartedSeptember 2, 2026
Main results expectedDecember 31, 2026
Study endsDecember 31, 2026
Registry record updatedSeptember 22, 2026
Trial IDNCT07746726 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults undergoing elective general anesthesia who can provide informed consent and meet the study’s eligibility criteria.

Probably not a fit

Patients with significant comorbidities affecting neuromuscular function or those who do not respond to study drugs may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adults scheduled for elective surgery under general anesthesia are randomized to receive either HRS-9190 or rocuronium to produce neuromuscular blockade. The study measures how well each drug facilitates tracheal intubation, how quickly it works, how long its effects last, and recovery patterns. Safety is monitored through adverse events, vital signs, lab tests, and other safety indicators. Primary goal is to determine if HRS-9190 provides comparable or superior blockade for intubation with an acceptable safety profile. Secondary goals include onset time, duration of action, maintenance time during surgery, and recovery trajectory.

Why it matters

Potential benefit: If successful, HRS-9190 could offer a safe and effective alternative to rocuronium for muscle relaxation during anesthesia.

How similar studies have gone: Previous research in similar neuromuscular blockers has demonstrated proof of concept; the success of HRS-9190 in this specific comparison remains to be established.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Able and willing to provide a written informed consent
2. Subjects requiring elective general anesthesia surgery
3. Meet specified age and body mass index (BMI) criteria
4. Conform to the ASA Physical Status Classification
5. Use of highly effective contraception for a specified period if applicable

Exclusion Criteria:

1. History of significant neuromuscular, cardiovascular, respiratory, or neurological disorders
2. History of conditions affecting drug metabolism or anesthesia risk
3. Abnormal laboratory values indicating significant clinical abnormalities
4. Positive serology for specified infectious diseases
5. Known hypersensitivity to related medications
6. Recent use of medications interfering with neuromuscular function
7. History of mental illness, cognitive impairment, or epilepsy
8. Participation in another clinical trial within a specified period
9. Any other condition deemed unsuitable by the investigator

Where it's running

  • The Third Xiangya Hospital of Central South University
    Changsha, Hunan, China
    Recruiting
  • The First Affiliated Hospital of Wenzhou Medical University
    Wenzhou, Zhejiang, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.